
Loading, please wait...

Loading, please wait...

Population-level genetic screening is becoming more common outside traditional clinical settings. However, the success of these programs depends on effective genetic results discussion between patients and their healthcare providers. A recent study, the Geno4ME genome sequencing project, analyzed participant behavior twelve months after receiving results. Shockingly, the data revealed that only 21% of participants discussed their findings with a clinician. This low engagement rate suggests that many patients may miss out on necessary adjustments to their long-term care plans.
Several factors play a pivotal role in whether a patient initiates a genetic results discussion. The presence of a pathogenic variant was the strongest predictor, increasing the likelihood of a discussion by over two times. Additionally, patients with a personal or family history of related conditions were more inclined to seek professional advice. Clinical connection also proved vital; those who had a check-up in the previous year or were recruited through a clinic were significantly more likely to share their results. Consequently, establishing a strong patient-provider relationship before testing may enhance follow-up rates.
Beyond clinical findings, socioeconomic and demographic factors influence communication. Patients with higher education levels and those who expressed strong motivations for testing were more proactive. Moreover, the study found that patients who perceived the results as highly relevant to their health were more likely to schedule a consultation. Therefore, improving health literacy and emphasizing the clinical utility of genetic data could be essential strategies for healthcare systems. Doctors should actively inquire about outside genetic testing during routine visits to bridge this communication gap.
Many patients may not understand the clinical implications of their results or may feel that the results are not urgent if they do not have a pathogenic variant. Lack of clear pathways for follow-up also contributes to this gap.
Providers can encourage discussion by maintaining regular clinical contact and educating patients on how genetic screening impacts personalized prevention and treatment strategies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Dickey L et al. Factors Influencing Patient Discussion of Genetic Test Results with Healthcare Providers: Insights from a Hospital-Based Population Genetic Screening Program. Genet Med. 2026 May 27. doi: undefined. PMID: 42200353.
Khoury MJ, et al. Implementing Genomic Medicine in Health Systems. Journal of Personalized Medicine. 2024.
Scheuner MT, et al. Patient-Provider Communication about Genetics. American Journal of Preventive Medicine. 2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study highlights that only 21% of patients discuss genetic screening results with providers, influenced by pathogenic variants and clinical contact....
3 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today